Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
Pollock-Barziv
Stacey M
SM
SickKids Transplant Centre, Department of Pediatrics, The Hospital for Sick Children and University of Toronto Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada. s.pollock.barziv@utoronto.ca
Finkelstein
Yaron
Y
Manlhiot
Cedric
C
Dipchand
Anne I
AI
Hebert
Diane
D
Ng
Vicky L
VL
Solomon
Melinda
M
McCrindle
Brian W
BW
Grant
David
D
D000293:Adolescent; D000465:Algorithms; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016015:Logistic Models; D008297:Male; D010349:Patient Compliance; D012189:Retrospective Studies; D012307:Risk Factors; D016559:Tacrolimus / Q000008:administration & dosage / Q000097:blood*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus